Brief: Foghorn Therapeutics Inc Provides Second Quarter 2022 Financial and Corporate Update

Foghorn Therapeutics

09/08/2022 12:55

Aug 9 (Reuters) - Foghorn Therapeutics Inc.  FHTX.O :
    * FOGHORN THERAPEUTICS INC. QTRLY NET LOSS WAS $27.3 MILLION

Source text for Eikon:  ID:nGNXbV3S8y 
Further company coverage:  FHTX.O